Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Navigation/Suche
- Forscher*innen
- Institutionen
- Projekte
- Publikationen
- Partner
- Geldgeber
- Ausstattung
- Knowhow
- Forschungsfelder
"Köpfe" der aktuellen Meldungen:
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Tang, Y; Fickert, P; Trauner, M; Marcus, N; Blomenkamp, K; Teckman, J.
Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
Am J Physiol Gastrointest Liver Physiol. 2016; 311(1):G156-G165
Doi: 10.1152/ajpgi.00143.2015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Fickert Peter
- Trauner Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The bile acid nor-ursodeoxycholic acid (norUDCA) has many biological actions, including antiapoptotic effects. Homozygous PIZZ α-1-antitrypsin (A1AT)-deficient humans are known to be at risk for liver disease, cirrhosis, and liver cancer as a result of the accumulation of the toxic, A1AT mutant Z protein within hepatocytes. This accumulation triggers cell death in the hepatocytes with the largest mutant Z-protein burdens, followed by compensatory proliferation. Proteolysis pathways within the hepatocyte, including autophagy, act to reduce the intracellular burden of A1AT Z protein. We hypothesized that norUDCA would reduce liver cell death and injury in A1AT deficiency. We treated groups of PiZ transgenic mice and wild-type mice with norUDCA or vehicle, orally, and examined the effects on the liver. The PiZ mouse is the best model of A1AT liver injury and recapitulates many features of the human liver disease. Mice treated with norUDCA demonstrated reduced hepatocellular death by compensatory hepatocellular proliferation as determined by bromodeoxyuridine incorporation (3.8% control, 0.88% treated, P < 0.04). Ki-67 staining as a marker for hepatocellular senescence and death was also reduced (P < 0.02). Reduced apoptotic signaling was associated with norUDCA, including reduced cleavage of caspases-3, -7, and -8 (all P < 0.05). We determined that norUDCA was associated with a >70% reduction in intrahepatic mutant Z protein (P < 0.01). A 32% increase in hepatic autophagy associated with norUDCA was the likely mechanism. norUDCA administration is associated with increased autophagy, reduced A1AT protein accumulation, and reduced liver injury in a model of A1AT deficiency. Copyright © 2016 the American Physiological Society.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Autophagy - drug effects
- Cells, Cultured -
- Deoxycholic Acid - analogs & derivatives
- Deoxycholic Acid - pharmacology
- Disease Models, Animal -
- Genetic Predisposition to Disease -
- Humans -
- Liver - drug effects
- Liver - enzymology
- Liver - pathology
- Liver Cirrhosis - enzymology
- Liver Cirrhosis - genetics
- Liver Cirrhosis - pathology
- Liver Cirrhosis - prevention & control
- Mice, Inbred C57BL -
- Mice, Transgenic -
- Mutation -
- Phenotype -
- Transfection -
- Ursodeoxycholic Acid - analogs & derivatives
- Ursodeoxycholic Acid - pharmacology
- alpha 1-Antitrypsin - genetics
- alpha 1-Antitrypsin - metabolism
- alpha 1-Antitrypsin Deficiency - drug therapy
- alpha 1-Antitrypsin Deficiency - enzymology
- alpha 1-Antitrypsin Deficiency - genetics
- Find related publications in this database (Keywords)
- liver
- protein conformation
- alpha-1-antitrypsin
- proteolysis